| Ada I Kercado, MED | |
|
Urb. Estancias De Yauco Calle Circonia M3, Yauco, PR 00698-2749 | |
| (787) 267-4016 | |
| (787) 267-4016 |
| Full Name | Ada I Kercado |
|---|---|
| Gender | Female |
| Speciality | Psychologist - School |
| Location | Urb. Estancias De Yauco Calle Circonia M3, Yauco, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003041237 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TS0200X | Psychologist - School | 1957 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ada I Kercado, MED Estancias De Yauco Calle Circonia M3, Yauco, PR 00698 Ph: (787) 267-4016 | Ada I Kercado, MED Urb. Estancias De Yauco Calle Circonia M3, Yauco, PR 00698-2749 Ph: (787) 267-4016 |
News Archive
Researchers in the United States have analyzed the effects that geographic factors have on the spread of COVID-19 disease. They found that the epidemic intensity is significantly influenced by crowding, with epidemics in densely-populated cities lasting longer and having a more significant overall incidence.
The researchers selected the human adenovirus type 5 on which to base their vaccine because this replication-defective vector had already been used in their Ebola vaccine, with an excellent safety and immunogenicity profile in a phase 1 trial. The current study aimed to produce a vaccine that could offer mucosal vaccination and enhanced protection against this respiratory virus.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2009.
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. today announced that King has resubmitted a New Drug Application for REMOXY® to the U.S. Food and Drug Administration in response to a Complete Response letter received by Pain Therapeutics in December 2008.
Does the growing number of psychiatric disorder diagnoses have an effect on people with mental illnesses? According to a new study, as definitions of mental illnesses become broader, people who show signs of depression and other common mental illnesses are less likely to evoke a supportive response from friends and family members as are people with other severe mental disorders.
› Verified 7 days ago
Dr. Adianet Montanez, PSY D. Psychologist Medicare: Medicare Enrolled Practice Location: Urb. Jardines De Borinquen A1, Yauco, PR 00698 Phone: 787-526-6394 | |
Dr. Gerardo Manuel Medina Rivera, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: Urb. Jardines De Borinquen A-1, Suite 2, Yauco, PR 00698 Phone: 787-913-1555 | |
Dr. Tania Campos, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 55 Calle Comercio, Yauco, PR 00698 Phone: 787-992-0043 | |
Yasmin Jimenez Seda, Psychologist Medicare: Not Enrolled in Medicare Practice Location: Calle Matienzo Cintron, Edif 23 Local 1, Yauco, PR 00698 Phone: 787-601-7198 | |
Dr. Victoria S. Larrieux Villanueva, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 66 Calle Mattei Lluberas, Yauco, PR 00698 Phone: 787-688-0862 | |
Darmiz E Mangual Ruiz, PSY D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 18 Baldorioty Local 4, Yauco, PR 00698 Phone: 787-267-6067 Fax: 787-250-4498 |